Compare Direxion Daily S&P 500 Bull 3X Shares (SPXL) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Direxion Daily S&P 500 Bull 3X Shares vs State Street SPDR S&P Biotech ETF — how do they compare? Direxion Daily S&P 500 Bull 3X Shares trades at $270.4, while State Street SPDR S&P Biotech ETF trades at $154.38. Which is the better fit depends on your goals.
| SPXL | XBI | |
|---|---|---|
Sector | Leveraged / Inverse | Broad Market / Factor |
52-Week High | $288.04 | $164.28 |
52-Week Low | $170.20 | $85.16 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SPXL is trading at $264.57, down 0.44% with a bearish technical signal. The ETF faces resistance at the 50-day moving average while support levels cluster around $262-$254. Recent news highlights S&P 500 valuation concerns with Shiller CAPE ratios approaching historic highs, creating headwinds for leveraged index products.
The leveraged ETF's performance remains tied to S&P 500 momentum amid mixed earnings sentiment. Key risks include market concentration in tech stocks and potential AI bubble concerns, while institutional analysis suggests the broader market may still deliver double-digit gains through 2026 despite valuation pressures.
XBI trades at $150.94, down 2.14% today, with technical indicators showing a bearish trend but oversold RSI suggesting potential near-term support. The ETF lacks traditional valuation metrics due to its structure, but recent news highlights strong biotech sector momentum, including a 17% monthly gain and robust M&A activity. Analyst coverage is limited to a single hold rating, reflecting cautious optimism amid sector volatility.
Outlook: Biotech sector tailwinds from M&A and AI-driven drug discovery offer upside, but high volatility and policy risks persist. Investors should weigh XBI's equal-weight exposure to small/mid-cap biotech against its elevated beta, with technical support near $149 critical for short-term direction.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Direxion Daily S&P 500 Bull 3X Shares
SPXL aims for 300% of the S&P 500's daily performance. It uses swaps and futures to provide 3x leverage, making it a high-risk tool for short-term traders. Due to daily resets, it is prone to volatility decay and is not intended for long-term holding.
Read more on SPXL →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
